letter . 2022 Mar 31;57(1):74–75. doi: 10.5045/br.2022.2021146
© 2022 Korean Society of Hematology
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Fig. 2.
Leukocytosis was gone after starting imatinib.